The first of its kind to approach early detection from a cross-disease focus, the Early Detection Summit provides the latest case studies and innovative strategies enabling accelerating early detection – from cancer, to diabetes, to arthritis.
Gain insights from leading pharma, biotech companies and academic researchers facilitating the new age of early detection tools, with a lens on collaborative working to advance research forward.
To find out more and to register click here.